Finding the right dose of sugammadex for infants after surgery
Treatments studied
This study tests different doses of a medicine called sugammadex to reverse the effects of a muscle relaxant (rocuronium) used during surgery in infants under 24 months old. It aims to find the best dose to help babies recover from anesthesia safely and quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is under 24 months old.
- Your baby is scheduled for a non-emergency surgery (or a relative emergency with more than 12 hours to prepare).
- Your baby is generally healthy (classified as ASA I or II).
- Your baby was born at 37 weeks or later (not premature).
- Your baby does not have a known allergy to the study medicines.
- You (the parent or guardian) can speak French and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of helping children wake up and breathe on their own after minimally invasive heart surgery. One group gets a drug to quickly reverse the muscle relaxant, while the other group waits for it to wear off naturally. The goal is to see which method allows a safer, earlier breathing tube removal.
This study tests a domestic version of sugammadex sodium (a drug that reverses muscle relaxants) after lung surgery. It aims to see how well it works to help you wake up and recover from anesthesia.
This trial tests a drug called sugammadex, which is used to reverse the effects of a muscle relaxant given during anesthesia. It is for adults having general or brain surgery, and aims to help you wake up and breathe more quickly after surgery.
This study compares how quickly two different drugs (a half dose of sugammadex and neostigmine) reverse the effects of the muscle relaxant rocuronium after laparoscopic gallbladder surgery. The goal is to find which drug helps you wake up and breathe normally faster.
This trial compares two medications given to reverse the effects of muscle relaxants after an outpatient ERCP (a scope procedure). The goal is to see which drug works better and faster, which could help you wake up more comfortably.
This study tests a drug called sugammadex that helps you wake up faster and breathe better after weight-loss surgery. It may help you recover more quickly and safely after your operation.
Hear when a new Curarization, Postoperative Residual trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.